Consolidated Statement Of Cash Flows

Sumitomo Pharma Co., Ltd. - Filing #7249083

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
23,634,000,000 JPY
23,634,000,000 JPY
JPY
1,000,000 JPY
23,635,000,000 JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
-314,969,000,000 JPY
JPY
JPY
40,000,000 JPY
JPY
JPY
JPY
-314,969,000,000 JPY
-314,929,000,000 JPY
JPY
Depreciation and amortization
25,562,000,000 JPY
37,765,000,000 JPY
Impairment losses (reversal of impairment losses)
5,189,000,000 JPY
180,857,000,000 JPY
Income tax expense
-6,024,000,000 JPY
-8,185,000,000 JPY
Decrease (increase) in inventories
18,837,000,000 JPY
-11,795,000,000 JPY
Increase (decrease) in provisions
-6,441,000,000 JPY
-52,908,000,000 JPY
Other
-11,074,000,000 JPY
-44,132,000,000 JPY
Subtotal
7,213,000,000 JPY
-203,613,000,000 JPY
Interest received
890,000,000 JPY
2,030,000,000 JPY
Dividends received
576,000,000 JPY
1,019,000,000 JPY
Interest paid
-4,361,000,000 JPY
-3,734,000,000 JPY
Income taxes paid
-1,892,000,000 JPY
-37,595,000,000 JPY
Net cash provided by (used in) operating activities
16,500,000,000 JPY
-241,893,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-8,498,000,000 JPY
-10,771,000,000 JPY
Proceeds from sale of property, plant and equipment
2,208,000,000 JPY
434,000,000 JPY
Purchase of intangible assets
-4,532,000,000 JPY
-4,959,000,000 JPY
Other
1,544,000,000 JPY
10,000,000,000 JPY
Net cash provided by (used in) investing activities
99,754,000,000 JPY
33,036,000,000 JPY
Cash flows from financing activities
Net increase (decrease) in short-term borrowings
-181,972,000,000 JPY
84,000,000,000 JPY
Proceeds from long-term borrowings
139,487,000,000 JPY
JPY
Repayments of long-term borrowings
-70,000,000,000 JPY
JPY
Dividends paid
-3,000,000 JPY
-2,792,000,000 JPY
Other
566,000,000 JPY
659,000,000 JPY
Net cash provided by (used in) financing activities
-108,836,000,000 JPY
77,851,000,000 JPY
Net increase (decrease) in cash and cash equivalents
7,418,000,000 JPY
-131,006,000,000 JPY
Cash and cash equivalents
23,116,000,000 JPY
29,047,000,000 JPY
143,478,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
-177,000,000 JPY
15,440,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.